Covance
Contact Us   |  Client Login  

  • PRODUCTS & SERVICES
    • Antibody Products
      • Antibody Products Store
      • Neuroscience
      • Epitope Tags
      • Structural Proteins & Cell Components
      • Signal Transduction
      • Immunopathology
      • Detection Chemistries & Ancillaries
      • Custom Immunology Services
    • Biopharmaceutical Development
    • Biorepository Services
    • Biotechnology Services
    • Chemistry, Manufacturing and Controls Pharmaceutical Development
    • Clinical Services
      • Bioanalytical
      • Central Laboratory
      • Clinical Development (Phase I-III)
    • Commercialization Services
      • Market Access
    • Discovery & Translational Services
      • Antibody Products
      • Biomarker Center of Excellence
      • BioPathways
      • Computational Biology
      • Discovery
      • Genomics Laboratory
      • Immunology
      • Vaccines & Infectious Disease
    • Environmental Sciences
    • Genomics Laboratory
    • Integration in Drug Development
    • Nonclinical Services
      • Antibody Products
      • Bioanalytical Services
      • Discovery
      • Drug Metabolism & Pharmacokinetics
      • Immunology
      • Radiosynthesis
      • Research Models
      • Safety Pharmacology
      • Toxicology
      • Vaccines & Infectious Disease
    • Nutritional Chemistry & Food Safety
    • Secure Data Access
    • Strategic Partnering

  • CAREERS
    • Search Jobs
    • College / University
    • Featured Jobs
    • Diversity
    • Benefits
    • 现在就加入科文斯中国!

  • STUDY PARTICIPANTS

  • INVESTORS
    • Investor Information
      • Investor Home
      • Stock Information
      • Board of Directors
      • Corporate Governance Guidelines
      • Analyst Coverage
      • Investor FAQ
      • Presentations & Webcasts
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Press Releases
    • Calendar of Events
    • Request Information

  • NEWS
    • Press Releases
    • Media Relations

  • ABOUT COVANCE
    • Company Overview
    • Global Locations
    • Corporate Responsibility
    • Business Integrity Program
    • Animal Welfare
    • Covance.Asia

  • RESOURCE CENTER
   
 
 
   

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.




Featured Events
AAPS-NBC
  21–23 May 2012

DIA 48th Annual Meeting -- Philadelphia
  24–28 June 2012

What's New
FAQ: UP/ESP Microbiology

Presentation: Drug-Transporter Interactions: Regulatory Perspectives & Relevance to Drug Development
Featured Jobs
Clinical Research Associate

Medical Technologist

China Opportunities

Covance Careers News
Annual Meeting Documents
View Our 2011 Annual Report and 2012 Proxy Statement
7 May2012
Covance To Present At The R. W. Baird 2012 Growth Stock Conference
2 May 2012
Covance Reports First Quarter Net Revenue Growth Of 5.7% To $531M, EPS Of $0.60, And Adjusted Net Orders Of $704M
2 May 2012
Covance Announces Executive Appointments
News: Read More
Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2012 Covance Inc. All rights reserved.